Differences in histopathological and biochemical outcomes in patients with low Gleason score prostate cancer-Reference-Cited by-同舟云学术

Differences in histopathological and biochemical outcomes in patients with low Gleason score prostate cancer

Published:2010-03 Issue:6 Volume:105 Page:818-823
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Isbarn Hendrik,Karakiewicz Pierre I.,Ahyai Sascha A.,Chun Felix K.H.,Jeldres Claudio,Haese Alexander,Heinzer Hans,Zacharias Mario,Heuer Roman,Eichelberg Christian,Steuber Thomas,Budäus Lars,Köllermann Jens,Salomon Georg,Schlomm Thorsten,Perrotte Paul,Fisch Margit,Huland Hartwig,Graefen Markus

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2009.08841.x/fullpdf

Reference22 articles.

1. Prostate carcinoma incidence and patient mortality: the effects of screening and early detection;Brawley;Cancer,1997

2. Competing risk analysis of men aged 55-74 years at diagnosis managed conservatively for clinically localized prostate cancer;Albertsen;JAMA,1998

3. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer;D’Amico;JAMA,1998

4. Assessing individual risk for prostate cancer;Nam;J Clin Oncol,2007

5. Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings;Epstein;J Urol,1998

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Significance of Accurate Determination of Gleason Score for Therapeutic Options and Prognosis of Prostate Cancer;Pathology & Oncology Research;2015-11-12

2. Évaluation préthérapeutique du patient candidat à la chirurgie du cancer de la prostate;Progrès en Urologie;2015-11

3. Comparison of clinical outcomes between upgraded pathologic Gleason score 3 + 4 and non-upgraded 3 + 4 prostate cancer among patients who are candidates for active surveillance;World Journal of Urology;2015-03-26

4. The Value of Prognostic Grouping of Prostatic Carcinomas for Urologists and Pathologists;Urologia Internationalis;2015

5. Epstein criteria for insignificant prostate cancer;BJU International;2011-02-14